国际标准期刊号: 2329-9053

分子药剂学与有机过程研究杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • 学术钥匙
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

The Protective Effect of Shen Qi Wan on Adenine-Induced Podocyte Injury

Zhiqiang Jiang

Podocyte injury is a common pathological feature of kidney diseases and contributes to renal dysfunction. Shen Qi Wan, a traditional Chinese medicine formulation, has been used for centuries in the management of kidney diseases. This study aimed to investigate the protective effect of Shen Qi Wan on adenine-induced podocyte injury. In vitro experiments were conducted using cultured podocytes exposed to adenine, while in vivo experiments utilized an adenine-induced podocyte injury animal model. The viability, morphology, and function of podocytes were assessed, along with renal function, histopathological changes, and molecular markers of podocyte injury. The results showed that Shen Qi Wan treatment significantly improved podocyte viability, preserved podocyte morphology, and enhanced podocyte function in vitro. In the animal model, Shen Qi Wan administration attenuated renal dysfunction, ameliorated histopathological changes, and reduced molecular markers of podocyte injury. These findings demonstrate the protective effect of Shen Qi Wan on adenine-induced podocyte injury, highlighting its potential therapeutic application in kidney diseases.